Assam Reporter

Periodontal Inflammation Market to Exhibit Moderate Growth Rate till 2030, Investigates DelveInsight | Key Companies – Noveome, Amyndas, Cortexyme, and Others

 Breaking News
  • No posts were found

Periodontal Inflammation Market to Exhibit Moderate Growth Rate till 2030, Investigates DelveInsight | Key Companies – Noveome, Amyndas, Cortexyme, and Others

December 21
18:16 2021
Periodontal Inflammation Market to Exhibit Moderate Growth Rate till 2030, Investigates DelveInsight | Key Companies - Noveome, Amyndas, Cortexyme, and Others
Delveinsight Business Research LLP
DelveInsight’s “Periodontal Inflammation Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Periodontal Inflammation Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Periodontal Inflammation market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Periodontal Inflammation Market

Periodontal Inflammation: An Overview

Periodontal diseases are mainly the result of infections and inflammation of the gums and bones that surround and support the teeth. In its early stage, called gingivitis, the gums can become swollen and red, and they may bleed. In its more serious form, called periodontitis, the gums can pull away from the tooth, bone can be lost, and the teeth may loosen or even fall out. Chronic and progressive periodontal disease is characterized by unresolved inflammation, fibrosis, and loss of tissue structure and function.

Periodontal Inflammation Market Key Facts

  • According to the Centers for Disease Control and Prevention (CDC), 47.2% of adults aged 30 years and older have some form of periodontal disease. Periodontal disease increases with age, 70.1% of adults 65 years and older have periodontal disease.

  • As per World Health Organization (WHO), severe periodontal (gum) disease is found in 5–20% of middle-aged (35–44 years) adults in Europe, and up to 40% of older people (65–74 years).

  • Overall, the prevalence of periodontal (gum) disease in adults has decreased from the early 1970s until the Latest (1999-2004) National Health and Nutrition Examination Survey. As per the National Institute of Dental and

  • Craniofacial Research (NIDCR) 8.52% of adults aged 20 to 64 have periodontal disease and 5.08% of adults 20 to 64 have moderate or severe periodontal disease. Moreover, men, older adults, and current smokers were more likely to have periodontal disease. 

Periodontal Inflammation Market 

Periodontal Inflammation Market size is expected to increase during the forecast period owing to the rise in the number of prevalent cases.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Periodontal Inflammation market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Periodontal Inflammation market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Get the PDF Sample of the Report:- Periodontal Inflammation Therapeutics Market

Periodontal Inflammation Epidemiology

The epidemiology section covers insights about the historical and current Periodontal Inflammation patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Periodontal Inflammation Epidemiology Segmentation

  • Severity-specific Prevalent Population of Periodontal Disease

  • Age-specific Prevalent Population of Periodontal Disease

  • Prevalent Population of Periodontal Disease

  • Diagnosed and Treatable Cases of Periodontal Disease 

  • Gender-specific Prevalent Population of Periodontal Disease

Periodontal Inflammation Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Periodontal Inflammation market or expected to get launched in the market during the study period. The analysis covers Periodontal Inflammation market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Periodontal Inflammation Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Periodontal Inflammation Therapeutics Analysis

The dynamics of the Periodontal Disease market is anticipated to change in the coming years owing to the improvement in the research & development activities and the launch of emerging therapies.

Some of the key companies in the Periodontal Inflammation Market include:

  • Noveome Biotherapeutics

  • Amyndas Pharmaceuticals

  • Cortexyme

And others 

Periodontal Inflammation Therapies covered in the report include:

  • ST266

  • AMY 101

  • Atuzaginstat

And many more

The pipeline of Periodontal Disease is very bleak with few potential key players. This showcases an unmet need for non-surgical therapies involving drugs for treating the condition. However, this scenario is expected to get better in the coming years.

Get More Detailed Insights into the Emerging Therapies & Key Companies:- https://www.delveinsight.com/sample-request/periodontal-inflammation-market

Table of Content

1. Key Insights

2. Executive Summary 

3. Periodontal Inflammation Competitive Intelligence Analysis

4. Periodontal Inflammation Market Overview at a Glance

5. Periodontal Inflammation Disease Background and Overview

6. Periodontal Inflammation Patient Journey

7. Periodontal Inflammation Epidemiology and Patient Population

8. Periodontal Inflammation Treatment Algorithm, Current Treatment, and Medical Practices

9. Periodontal Inflammation Unmet Needs

10. Key Endpoints of Periodontal Inflammation Treatment

11. Periodontal Inflammation Marketed Products

12. Periodontal Inflammation Emerging Therapies

13. Periodontal Inflammation Seven Major Market Analysis

14. Attribute Analysis

15. Periodontal Inflammation Market Outlook (7 major markets)

16. Periodontal Inflammation Access and Reimbursement Overview

17. KOL Views on the Periodontal Inflammation Market.

18. Periodontal Inflammation Market Drivers

19. Periodontal Inflammation Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Request Sample Report here:- https://www.delveinsight.com/sample-request/periodontal-inflammation-market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles